Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
BIND Therapeutics
4371
BIND Therapeutics
Health Care
Technology
Biotechnology
BIND Therapeutics is a clinical-stage nanomedicine platform company developing Accurins, a class of highly selective, targeted therapeutics.
Suggest edits
Founded
2006
Raised
$37.9M
Follow us
Also headquartered in Cambridge
MIT
Raspberry Pi
ARM
Biogen
Xconomy
HubSpot
Money Mover
Formlabs
Akamai
General Catalyst
Companies in the same industry
TargEDys
EnBiotix, Inc.
Rgenix
NestSense
Silverback Therapeutics
Repare Therapeutics
Deepcare
MaaT Pharma
CCG
ELPIS BIOMED LTD
Alexa global traffic share
Twitter followers
Overview
Funding
2
Add info
Add round
13 Feb
2012
$25,500,000
Venture capital (Series D)
RUSNANO
29 Jun
2010
$12,400,000
Venture capital (Series C)
Endeavour Vision
,
Flagship Ventures
,
Polaris Partners
,
+2